Strathmore Capital Advisors, Inc. Abbott Laboratories Transaction History
Strathmore Capital Advisors, Inc.
- $226 Billion
- Q2 2025
A detailed history of Strathmore Capital Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Strathmore Capital Advisors, Inc. holds 3,837 shares of ABT stock, worth $506,714. This represents 0.23% of its overall portfolio holdings.
Number of Shares
3,837Holding current value
$506,714% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,582Shares Held
1.37BCall Options Held
9.71MPut Options Held
8.85M-
Vanguard Group Inc Valley Forge, PA170MShares$22.4 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.3 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.3 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.82 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.7 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $231B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...